Singer D, Sweeney C, Stempniewicz N, Reynolds M, Garbinsky D, Poston S. Knowledge, attitudes, and practices regarding herpes zoster vaccination among specialists. Popul Health Manag. 2024 Jun 5. doi: 10.1089/pop.2023.0284
John NM, Wright SJ, Gavan SP, Vass CM. The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic review. Eur J Health Econ. 2019 Nov;20(8):1123-31. doi: 10.1007/s10198-019-01082-x
Pead E, Megaw R, Cameron J, Fleming A, Dhillon B, Trucco E, MacGillivray T. Automated detection of age-related macular degeneration in color fundus photography: a systematic review. Surv Ophthalmol. 2019 Jul 1;64(4):498-511. doi: 10.1016/j.survophthal.2019.02.003
Ten Eyck L, MacLeod S, Hawkins K, Guimont R, Hartley S. The impact of a heart failure management program in a medicare advantage population. Popul Health Manag. 2019 Apr;22(2):153-61. doi: 10.1089/pop.2018.0072
Bennett KJ, Probst JC, Bullard JC, Crouch E. The importance of rural hospitals: transfers and 30-day readmissions among rural residents and patients presenting at rural hospitals. Popul Health Manag. 2019 Apr;22(2):120-6. doi: 10.1089/pop.2018.0050
MacLeod S, Schwebke K, Hawkins K, Ruiz J, Hoo E, Yeh CS. Need for comprehensive health care quality measures for older adults. Popul Health Manag. 2018 Aug;21(4):296-302. doi: 10.1089/pop.2017.0109
Rajan SS, Suryavanshi MS, Karanth S, Lairson DR. The immediate impact of the 2009 USPSTF screening guideline change on physician recommendation of a screening mammogram: findings from a national ambulatory and medical care survey-based study. Popul Health Manag. 2017 Apr;20(2):155-64. doi: 10.1089/pop.2015.0180.
Wilson MR, Bergman A, Chevrou-Severac H, Selby R, Smyth M, Kerrigan MC. Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom. Eur J Health Econ. 2017 Mar;19(2):229-40. doi: 10.1007/s10198-017-0879-5.
Glück S, Russell C, O'Shaughnessy J, McKenna EF, Hu S, Odom D, Blum JL. Treatment effect of capecitabine and docetaxel or docetaxel alone by oestrogen receptor status in patients with metastatic breast cancer: results of an exploratory analysis. Breast. 2013 Dec;22(6):1087-93. doi: 10.1016/j.breast.2013.08.016.
Beard SM, von Scheele BG, Nuki G, Pearson IV. Cost-effectiveness of febuxostat in chronic gout. Eur J Health Econ. 2013 May;Advance online publication.
Mehta H, Patel J, Parikh RC, Abughosh S. Differences in obesity management among physicians. Popul Health Manag. 2012 Oct;15(5):287-92.
Greiner W, Lehmann K, Earnshaw S, Bug C, Sabatowski R. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany. Eur J Health Econ. 2006 Dec 1;7(4):290-6.
Lehmann K, Radbruch L, Gockel HH, Neighbors D, Nuyts G. Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Duragesic) with controlled release morphine. Eur J Health Econ. 2002;3:111-9. doi: 10.1007/s10198-002-0097-6.